What's new? This blog keeps you up-to-date with the latest news, events and campaigns at OLS.

European Cardio Symposium - Join Us!

Registration for ACEA Biosciences European Cardio Symposium is open

 

How Cancer Drug Doxorubicin induces Cardiotoxicity

A recent nature paper provides new insights how the anticancer agent Doxorubicin induces cytotoxicity in human induced pluripotent stem cells-derived cardiomyocytes (iPS-CMs).

 

Human iPSC-derived cardiomyocytes: Participate in a Wet Lab Demo of the ACEA Cardio ECR Analyzer in Cologne Bio Campus September 7 - 9, hosted by Axiogenesis.

 

ACEA Biosciences’ Cardio Symposium is a forum to promote scientific exchange and collaboration. Experts from both industry and academia will share their findings on combining human induced pluripotent stem cell-derived (hiPSC) cardiomyocytes, cellular impedance, MEA and other technologies for cardiac safety assessment and cardiovascular disease studies.

 

Evaluating Drug-Induced Proarrhythmic Risk Using the CardioECR System
Wednesday, March 11, 2015
16:00 CET

 

Registrieren Sie sich jetzt für ein Webinar am 08.10.2014 über den Einsatz von xCELLigence Technologie zur Untersuchung der Cardiotoxizität von Kinase-Inhibitoren.

 

Newsletter 6/2014
Durchflusszytometrie? Warum Sie jetzt einsteigen sollten! + Transfection Assays mit dem JuLI + JuLI Sommeraktion in der letzten Runde + xCELLigence Cardio Symposium in Basel - seien Sie noch mit dabei!

 

Register now for Cardiac Safety and Toxicology Symposium in Basel! Plus 2 spannende Artikel aus der xCELLigence RTCA Welt!